VIB INKS QBASE+ GROUP LICENSING AGREEMENT WITH BIOGAZELLE: http://t.co/EkimyQQSZW
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international stem cell storage company and the largest family stem cell bank in Europe, is pleased to announce that it has been included in the AScX® index, effective as of today, Monday 18 June 2012.
The AScX® index, also known as Small Cap index or simply Small Cap, is a stock market index composed of Dutch companies that trade on NYSE Euronext Amsterdam. It is composed of the 25 funds that trade on the exchange and that rank 51-75 in size. The inclusion is a result of the increased trade liquidity of the Cryo-Save share over the past 12 months.
Arnoud van Tulder, Chief Executive Officer, commented:
"We are pleased to be included in the Small Cap index. This will definitely further contribute to the name awareness and the trade liquidity of the Cryo-Save share, listed on NYSE Euronext Amsterdam."
Cryo-Save, the leading international family stem cell bank, stores more than 200,000 samples from umbilical cord blood, cord tissue and adipose tissue. There are already many diseases treatable by the use of stem cells, and the number of treatments will only increase. Driven by its international business strategy, Cryo-Save is now represented in over 40 countries on 3 continents, with ultra-modern processing and storage facilities in Belgium, Germany, Dubai, India and South Africa.
Tags: stock market